Effects of nasal positive expiratory pressure on dynamic hyperinflation and 6-minute walk test in patients with COPD

Respiratory Care

Volumn 59, Issue 5, 2014, Pages 699-708

  Wibmer, Thomas ^a   Rüdiger, Stefan ^a   Heitner, Claudia ^a   Kropf Sanchen, Cornelia ^a   Blanta, Ioanna ^a   Stoiber, Kathrin M ^a   Rottbauer, Wolfgang ^a   Schumann, Christian ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Airway resistance; Chronic obstructive pulmonary disease; Dyspnea; Lung capacities; Positive pressure respiration; Respiration

Indexed keywords

6 MINUTE WALK TEST; AGED; ARTICLE; BODY PLETHYSMOGRAPHY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; ENDURANCE TRAINING; EXERCISE; EXERCISE TEST; EXPIRATORY RESERVE VOLUME; FEMALE; FUNCTIONAL RESIDUAL CAPACITY; HEART RATE; HUMAN; HYPERINFLATION; INSPIRATORY CAPACITY; LUNG VOLUME; MALE; OXYGEN SATURATION; POSITIVE END EXPIRATORY PRESSURE; POSITIVE END EXPIRATORY PRESSURE VENTILATOR; RANDOMIZED CONTROLLED TRIAL; RESIDUAL VOLUME; SPIROMETRY; TOTAL LUNG CAPACITY; BLOOD; DEVICES; MASK; MIDDLE AGED; NOSE; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; WALKING;

OXYGEN;

AGED; CROSS-OVER STUDIES; EXERCISE TEST; FEMALE; HUMANS; MALE; MASKS; MIDDLE AGED; NOSE; OXYGEN; PLETHYSMOGRAPHY, WHOLE BODY; POSITIVE-PRESSURE RESPIRATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESIDUAL VOLUME; WALKING;

EID: 84899756325     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.02668     Document Type: Article

References (48)

1. Larsson K. Aspects on pathophysiological mechanisms in COPD. J Intern Med 2007;262(3):311-340.
2. Puente-Maestu L, Stringer WW. Hyperinflation and its management in COPD. Int J Chron Obstruct Pulmon Dis 2006;1(4):381-400.
3. O'Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol 2008; 105(2):753-755.
4. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006;119(10 SUPPL 1):21-31.
5. Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, López-Collazo E, Alvarez-Sala R. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009;180(6):506-512.
6. O'Donnell DE, D'Arsigny C, Fitzpatrick M, Webb KA. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. Am J Respir Crit Care Med 2002;166(5): 663-668.
7. Ferguson GT. Why does the lung hyperinflate? Proc Am Thorac Soc 2006;3(2):176-179.
8. Casaburi R, Porszasz J. Reduction of hyperinflation by pharmacologic and other interventions. Proc Am Thorac Soc 2006;3(2):185-189.
9. Baldi S, Oliaro A, Tabbia G, Bardessono M, Solidoro P, Mancuso M, et al. Lung volume reduction surgery 10 years later. J Cardiovasc Surg (Torino) 2012;53(6):809-815.
10. Martinez FJ, de Oca MM, Whyte RI, Stetz J, Gay SE, Celli BR. Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med 1997; 155(6):1984-1990.
11. Zoumot Z. Randomized Controlled Trial of RePneu Endobronchial Coils for the Treatment of Severe Emphysema With Hyperinflation (RESET). Chest 2012;142:1024A.
12. Sciurba FC, Ernst A, Herth FJF, Strange C, Criner GJ, Marquette CH, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010;363(13):1233-1244.
13. Barua A, Vaughan P, Wotton R, Naidu B. Do endobronchial valves improve outcomes in patients with emphysema? Interact Cardiovasc Thorac Surg 2012;15(6):1072-1076.
14. Van der Schans CP, de Jong W, de Vries G, Kaan WA, Postma DS, Koëter GH, et al. Effects of positive expiratory pressure breathing during exercise in patients with COPD. Chest 1994;105(3):782-789.
15. Spahija J, de Marchie M, Grassino A. Effects of imposed pursed-lips breathing on respiratory mechanics and dyspnea at rest and during exercise in COPD. Chest 2005;128(2):640-650.
16. Fagevik Olsén M, Westerdahl E. Positive expiratory pressure in patients with chronic obstructive pulmonary disease-a systematic review. Respiration 2009;77(1):110-118.
17. Cardoso DM, Paiva DN, Albuquerque IM, Jost RT, Paixão AV. Effects of expiratory positive airway pressure on the electromyographic activity of accessory inspiratory muscles in COPD patients. J Bras Pneumol 2011;37(1):46-53.
18. Padkao T, Boonsawat W, Jones CU. Conical-PEP is safe, reduces lung hyperinflation and contributes to improved exercise endurance in patients with COPD: a randomised cross-over trial. J Physiother 2010;56(1):33-39.
19. Monteiro MB, Berton DC, Moreira MAF, Menna-Barreto SS, Teixeira PJZ. Effects of expiratory positive airway pressure on dynamic hyperinflation during exercise in patients with COPD. Respir Care 2012;57(9):1405-1412.
20. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187(4):347-365.
21. O'Connell OJ, O'Farrell C, Harrison MJ, Eustace JA, Henry MT, Plant BJ. Nebulized hypertonic saline via positive expiratory pressure versus via jet nebulizer in patients with severe cystic fibrosis. Respir Care 2011;56(6):771-775.
22. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338.
23. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26(3):511-522.
24. Gibson GJ. Pulmonary hyperinflation a clinical overview. Eur Respir J 1996;9(12):2640-2649.
25. Quanjer PH. Standardized lung function testing. Report working party. Bull Eur Physiopathol Respir 1983;19(SUPPL 5):1-95.
26. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl 1993;16:5-40.
27. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166(1):111-117.
28. Borg BM, Thompson BR. The measurement of lung volumes using body plethysmography: a comparison of methodologies. Respir Care 2012;57(7):1076-1083.
29. O'Donnell DE, Guenette JA, Maltais F, Webb KA. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest 2012;141(3):753-762.
30. Yan S, Kaminski D, Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997;156(1):55-59.
31. Aliverti A, Stevenson N, Dellacà RL, Lo Mauro A, Pedotti A, Calverley PMA. Regional chest wall volumes during exercise in chronic obstructive pulmonary disease. Thorax 2004;59(3):210-216.
32. Calverley PMA, Koulouris NG. Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiology. Eur Respir J 2005;25(1):186-199.
33. O'Donnell DE, Laveneziana P. Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 2006;15(100):61-67.
34. Stubbing DG, Pengelly LD, Morse JL, Jones NL. Pulmonary mechanics during exercise in normal males. J Appl Physiol 1980;49(3):506-510.
35. O'Donnell DE, Forkert L, Webb KA. Evaluation of bronchodilator responses in patients with "irreversible" emphysema. Eur Respir J 2001;18(6):914-920.
36. Newton MF, O'Donnell DE, Forkert L. Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation. Chest 2002;121(4):1042-1050.
37. Marin JM, Carrizo SJ, Gascon M, Sanchez A, Gallego B, Celli BR. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001;163(6):1395-1399.
38. Callens E, Graba S, Gillet-Juvin K, Essalhi M, Bidaud-Chevalier B, Peiffer C, et al. Measurement of dynamic hyperinflation after a 6-minute walk test in patients with COPD. Chest 2009;136(6):1466-1472.
39. Pepin V, Brodeur J, Lacasse Y, Milot J, LeBlanc P, Whittom F, Maltais F. Six-minute walking versus shuttle walking: responsive-ness to bronchodilation in chronic obstructive pulmonary disease. Thorax 2007;62(4):291-298.
40. Morgan MDL, Singh SJ. Assessing the exercise response to a bronchodilator in COPD: time to get off your bike? Thorax 2007;62(4): 281-283.
41. Pessoa IM, Costa D, Velloso M, Mancuzo E, Reis MA, Parreira VF. Effects of noninvasive ventilation on dynamic hiperinflation of pa-tients with COPD during activities of daily living with upper limbs. Rev Bras Fisioter 2012;16(1):61-67.
42. Osadnik CR, McDonald CF, Jones AP, Holland AE. Airway clearance techniques for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;3:CD008328.
43. Martin AD, Davenport PW. Extrinsic threshold PEEP reduces postexercise dyspnea in COPD patients: a placebo-controlled, doubleblind cross-over study. Cardiopulm Phys Ther J 2011;22(3):5-10.
44. Schoene RB, Roach RC, Hackett PH, Harrison G, Mills WJ Jr. High altitude pulmonary edema and exercise at 4,400 meters on Mount McKinley. Effect of expiratory positive airway pressure. Chest 1985; 87(3):330-333.
45. Dechman G, Wilson CR. Evidence underlying breathing retraining in people with stable chronic obstructive pulmonary disease. Phys Ther 2004;84(12):1189-1197.
46. Williams AJ. Effect of oxygen on recovery from maximal exercise in COPD. Thorax 2005;60(3):257-258.
47. Williams AJ, Pitcher A, Thomas P, Baker R. P127 Does it matter how they breathe?-Perceptions in COPD patients when adopting different routes of breathing. Thorax 2010;65(SUPPL 4):A132-A132.
48. Faager G, Stâhle A, Larsen FF. Influence of spontaneous pursed lips breathing on walking endurance and oxygen saturation in patients with moderate to severe chronic obstructive pulmonary disease. Clin Rehabil 2008;22(8):675-683.